about
BRCA1 germline mutation and glioblastoma development: report of cases.Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancersCirculating microRNA-based screening tool for breast cancer.Mutation of the iron-sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy.MicroRNAs and Inflammation in Colorectal Cancer.Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample.Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine.Importance of post-transcriptional regulation of chemokine genes by oxidative stress.Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites.The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells.Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases.Impairment of the mitochondrial electron chain transport prevents NF-kappa B activation by hydrogen peroxide.Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity.Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.Innovative methodology for the identification of soluble biomarkers in fresh tissues.[Cancer therapy-induced cardiotoxicity]Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
P50
Q35226053-926DCB7A-66FC-4119-8238-2B8B40350A20Q35816698-6A22FF50-3463-4C78-A6FD-2B4D7E16BCB7Q36905676-229704C4-8780-4CBC-86D1-9505DEA1F380Q38875336-66A612EB-C819-4740-83DE-5A7DB603275CQ38940592-C37CED36-469F-419C-972E-247A828C3FD8Q38970049-57CF22EE-CEC1-4DBF-98B0-D71F3FBFCFA8Q39175226-B6657AC0-9536-4C0F-BDAC-C80DD25A99ACQ41916270-EFA3770B-D79E-4BD8-8561-9149B37E0BC7Q42091894-1990A9DD-CFC5-4628-A1E4-535C7963450DQ42172645-B1ABC085-DBF4-4BA5-B2FF-0EBE9B6AF228Q43148158-3CC86306-F188-4C90-9178-561ACD9A4E83Q43181972-9A607153-5723-4E87-A735-6C447693085EQ47107517-032250D4-7CEF-4D8E-B1CC-BC8F872A6F9FQ47138823-9B09CD40-67DB-466A-B429-B0AF998C4258Q47876988-1CA79F0B-FBE0-49BB-A607-D98D7CB96DD6Q48036342-ADAE8D17-D0F4-4E7F-AE2E-34247538197BQ48308600-1ECC7791-DC3E-4562-A86E-B6AAC693FAA6Q49163835-2C70AD6C-8497-425B-A300-4243E0C63CEEQ51119596-F5B7B306-13FA-4278-86E7-A988700C609CQ51734150-65CD3FC2-CA02-48E2-B96D-D84D996FCA32Q60231487-B435E201-7CBD-49B6-8A2F-B7EEF3027C8EQ92131878-04C045D4-548B-46DD-811E-FA4AEB588BEB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claire Josse
@ast
Claire Josse
@en
Claire Josse
@es
Claire Josse
@nl
Claire Josse
@sl
type
label
Claire Josse
@ast
Claire Josse
@en
Claire Josse
@es
Claire Josse
@nl
Claire Josse
@sl
prefLabel
Claire Josse
@ast
Claire Josse
@en
Claire Josse
@es
Claire Josse
@nl
Claire Josse
@sl
P106
P1153
6602779888
P21
P31
P3835
claire-josse
P496
0000-0003-0315-3718